Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sugar Pill

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01666665Phase 2/3Terminated

Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin

Showing all 1 trials

Research Network

Common Treatments

  • Sugar Pill1
  • Metformin1

Active Sponsors

  • The University of Texas Medical Branch, Galveston1
  • Shriners Hospitals for Children1

Top Investigators

Related Conditions

  • Insulin Resistance1
  • Hyperglycemia1

Activity Timeline